Body

CPAP improves sleeping glucose levels in type 2 diabetes patients with OSA

Westchester, Ill. –A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine suggests that screening type 2 diabetes patients for obstructive sleep apnea (OSA) and treating those who have OSA with continuous positive airway pressure (CPAP) therapy could improve the management of their hyperglycemia and might favorably influence their long-term prognosis.

Step out for PAD

You probably know that poor diet and lack of exercise can lead to dangerous deposits of fatty plaques in arteries. But it is not just the heart that is affected – blood flow can be blocked to the legs too, leading to pain when walking, immobility and even in extreme cases, amputation.

Approximately 20% of us will suffer from this peripheral artery disease (PAD) once we are 65 or over, and with risk factors including smoking, diabetes, obesity and high blood pressure it is on the rise. Surgical intervention can sometimes help, but the prognosis is not good.

Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer

A possible new therapeutic target for pancreatic cancer, the most lethal form of human cancer, has been identified in the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," according to researchers at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.

Immunity stronger at night than during day

The immune system's battle against invading bacteria reaches its peak activity at night and is lowest during the day.

Experiments with the laboratory model organism, Drosophila melanogaster, reveal that the specific immune response known as phagocytosis oscillates with the body's circadian rhythm, according to Stanford researchers who presented their findings at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.

Single adult stem cell can self renew, repair tissue damage in live mammal

The first demonstration that a single adult stem cell can self-renew in a mammal was reported at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.

The transplanted adult stem cell and its differentiated descendants restored lost function to mice with hind limb muscle tissue damage.

The adult stem cells used in the study, conducted at Stanford University, were isolated from a mixed population of satellite cells in the skeletal muscle of mice.

Method sorts out double-walled carbon nanotube problem

It's hard to study something with any rigor if the subject can't be produced uniformly and efficiently. Researchers who study double-walled carbon nanotubes -- nanomaterials with promising technological applications -- find themselves in just this predicament.

MIT nanotubes sniff out cancer agents in living cells

CAMBRIDGE, Mass.--MIT engineers have developed carbon nanotubes into sensors for cancer drugs and other DNA-damaging agents inside living cells.

The sensors, made of carbon nanotubes wrapped in DNA, can detect chemotherapy drugs such as cisplatin as well as environmental toxins and free radicals that damage DNA.

Preventing a broken heart: Research aims to reduce scarring from heart attacks

MADISON – A heart damaged by heart attack is usually broken, at least partially, for good. The injury causes excessive scar tissue to form, and this plays a role in permanently keeping heart muscle from working at full capacity.

Now researchers have identified a key molecule involved in controlling excessive scar tissue formation in mice following a heart attack. When they stopped the scarring from occurring, the scientists found that the animals' heart function greatly improved following the injury.

More food at lower cost

In the face of climate change, being able to increase crop yields by enabling plants to take up nutrients and water more efficiently becomes increasingly important, as fertiliser and water supplies incur significant energy and environmental costs.

New research from the University of Bristol, published today in Nature Cell Biology, has shown how to increase the length of root hairs on plants, potentially improving crop yields, as plants with longer root hairs take up minerals and water more efficiently.

Snoring or soaring? Strength of fruit-fly immune system varies

STANFORD, Calif. — A fruit fly's immune system can tell time, researchers at the Stanford University School of Medicine have found, and how hard it punches back against infections depends on whether the fly is snoozing or cruising. The discovery could have implications for human health, too.

Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane

San Antonio – An interim analysis of a breast cancer prevention study using exemestane (Aromasin®) finds an "acceptable" level of bone loss.

Alternating mammography and MRI may be best for high-risk women

SAN ANTONIO - Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium.

Breast cancer risk varies in young women with benign breast disease, Mayo Clinic researchers say

SAN ANTONIO - A type of benign breast disease (BBD) known as atypical hyperplasia substantially increases a young woman's risk of developing breast cancer, even if there is no history of breast cancer in her family, say researchers at Mayo Clinic.

Mayo Clinic research on tamoxifen leads to recommendation for CYP2D6 gene test

SAN ANTONIO - Findings from a new study have prompted Mayo Clinic researchers to recommend CYP2D6 gene testing for postmenopausal women about to begin tamoxifen therapy. This data confirms that women with an inherited deficiency in the CYP2D6 gene, which is important for the metabolism of tamoxifen, have a nearly fourfold higher risk of early breast cancer recurrence compared to women who have not inherited the deficiency.

Tau protein expression predicts breast cancer survival -- though not as expected

SAN ANTONIO - Expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy, according to research led by The University of Texas M. D. Anderson Cancer Center.

Presented today, Dec. 13, at the CRTC-AACR San Antonio Breast Cancer Symposium, the researchers found that Tau expression does predict survival, yet in an unexpected way.